Jin Medical International Ltd. ZJYL
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Chart by TradingView
3/9
Piotroski F — financial health
5.16
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financials | ||||
| Revenue | $20.7M | $23.5M | $19.8M | $19.2M |
| Gross profit | $6.0M | $9.5M | $6.8M | $6.2M |
| Operating income | $608,182 | $3.6M | $2.9M | $2.1M |
| Net income | $1.2M | $3.7M | $2.9M | $2.7M |
| Operating cash flow | $2.9M | -$1.2M | $3.1M | $1.6M |
| Free cash flow | -$3.7M | -$1.4M | $3.0M | $1.5M |
| Total assets | $53.4M | $45.8M | $32.9M | $20.9M |
| Total liabilities | $23.8M | $17.2M | $8.9M | $5.7M |
| Shareholders' equity | $29.6M | $28.8M | $24.0M | $15.2M |
| Ratios | ||||
| Gross margin | 29.2% | 40.4% | 34.2% | 32.3% |
| Operating margin | 2.9% | 15.5% | 14.5% | 11.1% |
| Net margin | 5.8% | 15.6% | 14.5% | 14.1% |
| FCF margin | -18.0% | -5.8% | 15.1% | 8.0% |
| Return on assets | 2.2% | 8.0% | 8.7% | 12.9% |
| Return on equity | 4.0% | 12.8% | 12.0% | 17.8% |
| Current ratio | 1.86 | 2.50 | 3.49 | 3.31 |
| Revenue growth | -12.0% | 18.6% | 3.3% | — |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 5.16 (safe)
- Working capital / assets 0.381
- Retained earnings / assets 0.392
- EBIT / assets 0.011
- Equity / liabilities 1.243
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001837821 · as of 2025-09-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.